China-Japan Friendship Hospital
Beijing, No. 2, Xinghua East Street, Chaoyang District, China
NCT Number: NCT07486622
This study evaluates the feasibility, safety, and efficiency of transvaginal in-bag electromechanical morcellation for specimen extraction in patients undergoing total laparoscopic hysterectomy for large uteri.
This study is active but is not currently recruiting participants.
Notify Me38 year–52 year
Female
Observational
Beijing, No. 2, Xinghua East Street, Chaoyang District, China
This single-center prospective study investigates a novel transvaginal specimen extraction technique using a sealed containment bag combined with electromechanical morcellation. The procedure aims to improve specimen extraction efficiency while preventing tissue dissemination during laparoscopic hysterectomy for uteri larger than 12-week gestational size.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Female patients aged 38 to 52 years
Planned to undergo total laparoscopic hysterectomy
Uterine size greater than 12 weeks gestational size based on preoperative imaging
Eligible for transvaginal specimen extraction
Able and willing to provide written informed consent
Exclusion criteria
Advanced gynecologic malignancy
Severe pelvic obliteration preventing transvaginal access
Contraindication to laparoscopic surgery
Pregnancy
Inability or unwillingness to provide informed consent
Time frame: Immediately after specimen extraction
Integrity of the specimen containment bag assessed using methylene blue leakage testing following specimen extraction
Time frame: Periprocedurally
Duration required to complete transvaginal in-bag electromechanical morcellation and removal of the uterine specimen, measured in minutes.
Time frame: Immediately after surgery
Total duration of surgery measured from skin incision to completion of wound closure.
Time frame: During surgery
Estimated blood loss recorded during the surgical procedure.
Time frame: Up to 30 days postoperatively
Incidence of postoperative complications including infection, fever, or organ injury.
Time frame: Up to 7 days postoperatively
Number of days from surgery until hospital discharge.
Chang Zhou
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04126824
Adenomyosis, Female Urogenital Diseases
Westwood, Los Angeles, California, United States
View Trial DetailsNCT01992718
Adenomyosis, Female Urogenital Diseases
Ann Arbor, Michigan, United States
View Trial DetailsNCT02192606
Abnormal Uterine Bleeding, Adenomyosis
Boston, Massachusetts, United States
View Trial DetailsNCT00354471
Adenomyosis, Female Urogenital Diseases
Winnipeg, Manitoba, Canada
View Trial Details